Myeloma Crowd Radio

Upcoming Shows

Our Next Show: Up Next at UPENN – Building on the CAR 19 Multiple Myeloma Success and Beyond with Dr. Adam Cohen, Thursday, October 8 @ 2 pm CST


Thursday, October 8, Noon PST, 1 pm MST, 2 pm CST, 3 pm EST 

Call In by Phone to Listen Live: (347) 637-2631 or Listen Live Via Computer

The University of Pennsylvania had tremendous results with a recent clinical trial using a CAR T cell treatment targeting CD19 for a myeloma patient. The results were so impressive that some wonder if they have been able to eliminate the myeloma stem cell clone for one patient who had relapsed 9 therapies and had a high-risk genetic feature. Learn more about this success and where UPENN is heading next using this powerful CAR therapy with Dr. Adam Cohen, MD, Director of Myeloma Immunotherapy at the Perelman Center for Advanced Medicine at UPENN.

Dr. Cohen is Assistant Professor and Director of Myeloma Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania.

He regularly lectures to internal medicine residents and hematology /oncology fellows and at hematology conferences. He is a member of the Oncology Evaluation Center Practice Task Force, the Clinical Trials Scientific Review and Monitoring Committee, and is a Clinical Advisory Board Member for Managing Myeloma (online educational resource that has very valuable videos for oncologists.) He is on the Cancer Immunotherapy Guidelines/Hematologic Malignancies Task Force, the Society for Immunotherapy of Cancer (SITC), and is a member of ASCO’s Scientific Program Committee for Hematologic Malignancies.

Dr. Cohen reviews journal publications from Blood, Amyloid, Clinical Cancer Research, Journal of Translational Medicine, Annals of Oncology, Cytotherapy, Clinical Lymphoma Myeloma & Leukemia, Haematologica, PLOS One, OncoImmunology, Leukemia, and Human Vaccines and Immunotherapeutics. His most recent awards include Best Abstract in Myeloma; Lymphoma and Myeloma at the International Congress on Hematologic Malignancies, the Fox Chase Leadership Forum Excellence Award, and the ECOG Young Investigator Symposium .

He is a member of the Multiple Myeloma Committee, Eastern Cooperative Oncology Group, which helps create and oversee myeloma clinical trials and is a scientific advisor for the Myeloma Beacon.


Thanks to our episode sponsor, Amgen.amgen-logo-300x100

Myeloma Crowd Radio Episodes